Glucagon-like peptide-1 (GLP-1) agonist therapies are increasingly being used for type 2 diabetes and obesity, but evidence now shows they also reduce inflammation across multiple organs through mechanisms related and unrelated to weight-loss-driven metabolic improvements
But the papers authors, including researchers at Case Western Reserve University and Nora Volkow, the director of the National Institute on Drug Abuse, cautioned that the link between GLP-1 drugs and prevention of overdose deaths is unclear and that more research is needed, including randomized controlled trials
Complete Vegan Protein Powder Plus Vanilla Discover the benefits of Complete Vegan Protein Powder Plus Vanilla - a premium quality supplement designed to support your health and wellness journey
The combined application of systemic and topical analgesia, as well as the integration of patient-controlled analgesia with multimodal approaches, has attracted increasing attention in clinical settings
If you experience severe abdominal pain, call your doctor